PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports Third Quarter 2021 Financial Results

03 11 2021 08:00:03 提供 Nasdaq GlobeNewswire

Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition

02 11 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021

27 10 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

11 10 2021 07:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL

08 10 2021 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®

04 10 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

30 9 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

21 9 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021

15 9 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

08 9 2021 08:00:04 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

10 8 2021 08:00:02 提供 Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

04 8 2021 08:00:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

03 8 2021 08:00:03 提供 Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

02 8 2021 08:00:01 提供 Nasdaq GlobeNewswire

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

29 7 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021

20 7 2021 07:30:00 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

13 7 2021 08:00:03 提供 Nasdaq GlobeNewswire

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

22 6 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

08 6 2021 08:00:01 提供 Nasdaq GlobeNewswire

Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

26 5 2021 08:00:01 提供 Nasdaq GlobeNewswire